Efficacy/Safety of Midurethral Sling

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexFemale
Age30-100
SponsorMackay Medical College

About this trial

The trans-obturator tape (TOT), which exhibits a satisfactory cure rate and a relatively diminished invasiveness, has been increasingly accepted as a surgical treatment of stress urinary incontinence (SUI) patients. Nevertheless, in contrast to the well-recognized therapeutic benefit of the enhanced resistance to the bladder continence during urine storage, if the voiding function of the bladder adapts to the TOT-enhanced outlet resistance has not been adequately investigated. This study retrospectively assayed the voiding efficacy of each voiding cycle, to clarify if the thermodynamic efficacy of the bladder was modified in response to the TOT surgery.

Eligibility criteria

Qualifiers

Clinical diagnosis of stress urinary incontience

Have urodynamic investigations before and after operation.

Disqualifiers

Exclusion criteria will be a history of (1) cardiovascular, (2) neurological, or (3) other medical (such as diabetes or inflammation) problems as well as (4) patients who received a concomitant surgical procedure.

Trial design

Treatments tested in this trial

  • Urodynamic investigations before and after a trans-obturator tape protocol.
  • Urodynamic investigations before and after a tension-free vaginal tape-obturator (TVT-O)
  • Urodynamic investigations before and after a mini Arc protocol.
  • Urodynamic investigations before and after an i-STOP mini adjustable sling protocol.
  • Urodynamic investigations before and after an Solyx sling protocol.

Treatment groups

200 Participants
are divided into 34 treatment groups

34

Treatment groups

See each treatment group below.

Sponsors and collaborators